Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2008European Journal of Endocrinology

The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation

View Full Paper
Ask AI
Bookmark
Share

Authors

HPHa PhanCenter for Promotion of Advancement of SocietyPJPieter L. JagerIsalaJWJacqueline E. van der WalUniversity Medical Center Groningen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Phan et al. (2008) studied this question.

synapsesocial.com/papers/6a8564c4a46f793aa75e20d7https://doi.org/10.1530/eje-07-0399
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Follow-Up of Low Risk Patients with Papillary Thyroid Cancer: Role of Neck Ultrasonography in Detecting Lymph Node Metastases2004 · 243 citations
  2. 2Thyroglobulin may be undetectable in the serum of patients with metastatic disease secondary to differentiated thyroid carcinoma. Follow-up of differentiated thyroid carcinoma1984 · 54 citations
  3. 3Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis2005 · 147 citations
  4. 4Serum Thyroglobulin Autoantibodies: Prevalence, Influence on Serum Thyroglobulin Measurement, and Prognostic Significance in Patients with Differentiated Thyroid Carcinoma<sup>1</sup>1998 · 456 citations
  5. 5Clinical Impact of Thyroglobulin (Tg) and Tg Autoantibody Method Differences on the Management of Patients with Differentiated Thyroid Carcinomas2005 · 284 citations